Oncotelic (OTLC) Reports Form 4 Filing; Date: June 17

Oncotelic Therapeutics Inc (OTLC) filed a Form 4 on June 17, detailing insider trading activity. Form 4 filings are important as they disclose changes in ownership within a company, which can indicate insider confidence or concerns. The specific details of the trades, including the number of shares or any price changes, were not mentioned in the article. Such disclosures can impact investor perception and trading volumes, particularly for smaller companies like Oncotelic.